Global Cancer Gene Therapy Market Insights, Forecast to 2029

Global Cancer Gene Therapy Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Oncolytic Virotherapy
1.2.3 Gene Transfer
1.2.4 Gene-Induced Immunotherapy
1.3 Market by Application
1.3.1 Global Cancer Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Gene Therapy Market Perspective (2018-2029)
2.2 Global Cancer Gene Therapy Growth Trends by Region
2.2.1 Cancer Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cancer Gene Therapy Historic Market Size by Region (2018-2023)
2.2.3 Cancer Gene Therapy Forecasted Market Size by Region (2024-2029)
2.3 Cancer Gene Therapy Market Dynamics
2.3.1 Cancer Gene Therapy Industry Trends
2.3.2 Cancer Gene Therapy Market Drivers
2.3.3 Cancer Gene Therapy Market Challenges
2.3.4 Cancer Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cancer Gene Therapy by Players
3.1.1 Global Cancer Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Cancer Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cancer Gene Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Cancer Gene Therapy Market Concentration Ratio
3.4.1 Global Cancer Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Gene Therapy Revenue in 2022
3.5 Global Key Players of Cancer Gene Therapy Head office and Area Served
3.6 Global Key Players of Cancer Gene Therapy, Product and Application
3.7 Global Key Players of Cancer Gene Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Gene Therapy Breakdown Data by Type
4.1 Global Cancer Gene Therapy Historic Market Size by Type (2018-2023)
4.2 Global Cancer Gene Therapy Forecasted Market Size by Type (2024-2029)
5 Cancer Gene Therapy Breakdown Data by Application
5.1 Global Cancer Gene Therapy Historic Market Size by Application (2018-2023)
5.2 Global Cancer Gene Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cancer Gene Therapy Market Size (2018-2029)
6.2 North America Cancer Gene Therapy Market Size by Type
6.2.1 North America Cancer Gene Therapy Market Size by Type (2018-2023)
6.2.2 North America Cancer Gene Therapy Market Size by Type (2024-2029)
6.2.3 North America Cancer Gene Therapy Market Share by Type (2018-2029)
6.3 North America Cancer Gene Therapy Market Size by Application
6.3.1 North America Cancer Gene Therapy Market Size by Application (2018-2023)
6.3.2 North America Cancer Gene Therapy Market Size by Application (2024-2029)
6.3.3 North America Cancer Gene Therapy Market Share by Application (2018-2029)
6.4 North America Cancer Gene Therapy Market Size by Country
6.4.1 North America Cancer Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Cancer Gene Therapy Market Size by Country (2018-2023)
6.4.3 North America Cancer Gene Therapy Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Cancer Gene Therapy Market Size (2018-2029)
7.2 Europe Cancer Gene Therapy Market Size by Type
7.2.1 Europe Cancer Gene Therapy Market Size by Type (2018-2023)
7.2.2 Europe Cancer Gene Therapy Market Size by Type (2024-2029)
7.2.3 Europe Cancer Gene Therapy Market Share by Type (2018-2029)
7.3 Europe Cancer Gene Therapy Market Size by Application
7.3.1 Europe Cancer Gene Therapy Market Size by Application (2018-2023)
7.3.2 Europe Cancer Gene Therapy Market Size by Application (2024-2029)
7.3.3 Europe Cancer Gene Therapy Market Share by Application (2018-2029)
7.4 Europe Cancer Gene Therapy Market Size by Country
7.4.1 Europe Cancer Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Cancer Gene Therapy Market Size by Country (2018-2023)
7.4.3 Europe Cancer Gene Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cancer Gene Therapy Market Size (2018-2029)
8.2 China Cancer Gene Therapy Market Size by Type
8.2.1 China Cancer Gene Therapy Market Size by Type (2018-2023)
8.2.2 China Cancer Gene Therapy Market Size by Type (2024-2029)
8.2.3 China Cancer Gene Therapy Market Share by Type (2018-2029)
8.3 China Cancer Gene Therapy Market Size by Application
8.3.1 China Cancer Gene Therapy Market Size by Application (2018-2023)
8.3.2 China Cancer Gene Therapy Market Size by Application (2024-2029)
8.3.3 China Cancer Gene Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Cancer Gene Therapy Market Size (2018-2029)
9.2 Asia Cancer Gene Therapy Market Size by Type
9.2.1 Asia Cancer Gene Therapy Market Size by Type (2018-2023)
9.2.2 Asia Cancer Gene Therapy Market Size by Type (2024-2029)
9.2.3 Asia Cancer Gene Therapy Market Share by Type (2018-2029)
9.3 Asia Cancer Gene Therapy Market Size by Application
9.3.1 Asia Cancer Gene Therapy Market Size by Application (2018-2023)
9.3.2 Asia Cancer Gene Therapy Market Size by Application (2024-2029)
9.3.3 Asia Cancer Gene Therapy Market Share by Application (2018-2029)
9.4 Asia Cancer Gene Therapy Market Size by Region
9.4.1 Asia Cancer Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Cancer Gene Therapy Market Size by Region (2018-2023)
9.4.3 Asia Cancer Gene Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cancer Gene Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Cancer Gene Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Cancer Gene Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Details
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune Cancer Gene Therapy Introduction
11.1.4 Adaptimmune Revenue in Cancer Gene Therapy Business (2018-2023)
11.1.5 Adaptimmune Recent Developments
11.2 Bluebird bio
11.2.1 Bluebird bio Company Details
11.2.2 Bluebird bio Business Overview
11.2.3 Bluebird bio Cancer Gene Therapy Introduction
11.2.4 Bluebird bio Revenue in Cancer Gene Therapy Business (2018-2023)
11.2.5 Bluebird bio Recent Developments
11.3 Celgene
11.3.1 Celgene Company Details
11.3.2 Celgene Business Overview
11.3.3 Celgene Cancer Gene Therapy Introduction
11.3.4 Celgene Revenue in Cancer Gene Therapy Business (2018-2023)
11.3.5 Celgene Recent Developments
11.4 Shanghai Sunway Biotech
11.4.1 Shanghai Sunway Biotech Company Details
11.4.2 Shanghai Sunway Biotech Business Overview
11.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Introduction
11.4.4 Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2018-2023)
11.4.5 Shanghai Sunway Biotech Recent Developments
11.5 Shenzhen SiBiono GeneTech
11.5.1 Shenzhen SiBiono GeneTech Company Details
11.5.2 Shenzhen SiBiono GeneTech Business Overview
11.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Introduction
11.5.4 Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2018-2023)
11.5.5 Shenzhen SiBiono GeneTech Recent Developments
11.6 SynerGene Therapeutics
11.6.1 SynerGene Therapeutics Company Details
11.6.2 SynerGene Therapeutics Business Overview
11.6.3 SynerGene Therapeutics Cancer Gene Therapy Introduction
11.6.4 SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2018-2023)
11.6.5 SynerGene Therapeutics Recent Developments
11.7 Altor BioScience
11.7.1 Altor BioScience Company Details
11.7.2 Altor BioScience Business Overview
11.7.3 Altor BioScience Cancer Gene Therapy Introduction
11.7.4 Altor BioScience Revenue in Cancer Gene Therapy Business (2018-2023)
11.7.5 Altor BioScience Recent Developments
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Cancer Gene Therapy Introduction
11.8.4 Amgen Revenue in Cancer Gene Therapy Business (2018-2023)
11.8.5 Amgen Recent Developments
11.9 Argenx
11.9.1 Argenx Company Details
11.9.2 Argenx Business Overview
11.9.3 Argenx Cancer Gene Therapy Introduction
11.9.4 Argenx Revenue in Cancer Gene Therapy Business (2018-2023)
11.9.5 Argenx Recent Developments
11.10 BioCancell
11.10.1 BioCancell Company Details
11.10.2 BioCancell Business Overview
11.10.3 BioCancell Cancer Gene Therapy Introduction
11.10.4 BioCancell Revenue in Cancer Gene Therapy Business (2018-2023)
11.10.5 BioCancell Recent Developments
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Details
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Cancer Gene Therapy Introduction
11.11.4 GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2018-2023)
11.11.5 GlaxoSmithKline Recent Developments
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Cancer Gene Therapy Introduction
11.12.4 Merck Revenue in Cancer Gene Therapy Business (2018-2023)
11.12.5 Merck Recent Developments
11.13 OncoGenex Pharmaceuticals
11.13.1 OncoGenex Pharmaceuticals Company Details
11.13.2 OncoGenex Pharmaceuticals Business Overview
11.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Introduction
11.13.4 OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2018-2023)
11.13.5 OncoGenex Pharmaceuticals Recent Developments
11.14 Transgene
11.14.1 Transgene Company Details
11.14.2 Transgene Business Overview
11.14.3 Transgene Cancer Gene Therapy Introduction
11.14.4 Transgene Revenue in Cancer Gene Therapy Business (2018-2023)
11.14.5 Transgene Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cancer Gene Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Oncolytic Virotherapy
Table 3. Key Players of Gene Transfer
Table 4. Key Players of Gene-Induced Immunotherapy
Table 5. Global Cancer Gene Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Cancer Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Cancer Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Cancer Gene Therapy Market Share by Region (2018-2023)
Table 9. Global Cancer Gene Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Cancer Gene Therapy Market Share by Region (2024-2029)
Table 11. Cancer Gene Therapy Market Trends
Table 12. Cancer Gene Therapy Market Drivers
Table 13. Cancer Gene Therapy Market Challenges
Table 14. Cancer Gene Therapy Market Restraints
Table 15. Global Cancer Gene Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Cancer Gene Therapy Revenue Share by Players (2018-2023)
Table 17. Global Top Cancer Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2022)
Table 18. Global Cancer Gene Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Cancer Gene Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Cancer Gene Therapy, Headquarters and Area Served
Table 21. Global Key Players of Cancer Gene Therapy, Product and Application
Table 22. Global Key Players of Cancer Gene Therapy, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Cancer Gene Therapy Revenue Market Share by Type (2018-2023)
Table 26. Global Cancer Gene Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Cancer Gene Therapy Revenue Market Share by Type (2024-2029)
Table 28. Global Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Cancer Gene Therapy Revenue Share by Application (2018-2023)
Table 30. Global Cancer Gene Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Cancer Gene Therapy Revenue Share by Application (2024-2029)
Table 32. North America Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Cancer Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Cancer Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Cancer Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Cancer Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Cancer Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Cancer Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Cancer Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Cancer Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Cancer Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Cancer Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Cancer Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Cancer Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Cancer Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Cancer Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Cancer Gene Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Cancer Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Cancer Gene Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Cancer Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 64. Adaptimmune Company Details
Table 65. Adaptimmune Business Overview
Table 66. Adaptimmune Cancer Gene Therapy Product
Table 67. Adaptimmune Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 68. Adaptimmune Recent Developments
Table 69. Bluebird bio Company Details
Table 70. Bluebird bio Business Overview
Table 71. Bluebird bio Cancer Gene Therapy Product
Table 72. Bluebird bio Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 73. Bluebird bio Recent Developments
Table 74. Celgene Company Details
Table 75. Celgene Business Overview
Table 76. Celgene Cancer Gene Therapy Product
Table 77. Celgene Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 78. Celgene Recent Developments
Table 79. Shanghai Sunway Biotech Company Details
Table 80. Shanghai Sunway Biotech Business Overview
Table 81. Shanghai Sunway Biotech Cancer Gene Therapy Product
Table 82. Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 83. Shanghai Sunway Biotech Recent Developments
Table 84. Shenzhen SiBiono GeneTech Company Details
Table 85. Shenzhen SiBiono GeneTech Business Overview
Table 86. Shenzhen SiBiono GeneTech Cancer Gene Therapy Product
Table 87. Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 88. Shenzhen SiBiono GeneTech Recent Developments
Table 89. SynerGene Therapeutics Company Details
Table 90. SynerGene Therapeutics Business Overview
Table 91. SynerGene Therapeutics Cancer Gene Therapy Product
Table 92. SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 93. SynerGene Therapeutics Recent Developments
Table 94. Altor BioScience Company Details
Table 95. Altor BioScience Business Overview
Table 96. Altor BioScience Cancer Gene Therapy Product
Table 97. Altor BioScience Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 98. Altor BioScience Recent Developments
Table 99. Amgen Company Details
Table 100. Amgen Business Overview
Table 101. Amgen Cancer Gene Therapy Product
Table 102. Amgen Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 103. Amgen Recent Developments
Table 104. Argenx Company Details
Table 105. Argenx Business Overview
Table 106. Argenx Cancer Gene Therapy Product
Table 107. Argenx Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 108. Argenx Recent Developments
Table 109. BioCancell Company Details
Table 110. BioCancell Business Overview
Table 111. BioCancell Cancer Gene Therapy Product
Table 112. BioCancell Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 113. BioCancell Recent Developments
Table 114. GlaxoSmithKline Company Details
Table 115. GlaxoSmithKline Business Overview
Table 116. GlaxoSmithKline Cancer Gene Therapy Product
Table 117. GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 118. GlaxoSmithKline Recent Developments
Table 119. Merck Company Details
Table 120. Merck Business Overview
Table 121. Merck Cancer Gene Therapy Product
Table 122. Merck Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 123. Merck Recent Developments
Table 124. OncoGenex Pharmaceuticals Company Details
Table 125. OncoGenex Pharmaceuticals Business Overview
Table 126. OncoGenex Pharmaceuticals Cancer Gene Therapy Product
Table 127. OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 128. OncoGenex Pharmaceuticals Recent Developments
Table 129. Transgene Company Details
Table 130. Transgene Business Overview
Table 131. Transgene Cancer Gene Therapy Product
Table 132. Transgene Revenue in Cancer Gene Therapy Business (2018-2023) & (US$ Million)
Table 133. Transgene Recent Developments
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Cancer Gene Therapy Market Share by Type: 2022 VS 2029
Figure 3. Oncolytic Virotherapy Features
Figure 4. Gene Transfer Features
Figure 5. Gene-Induced Immunotherapy Features
Figure 6. Global Cancer Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Cancer Gene Therapy Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Diagnostics Centers Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Cancer Gene Therapy Report Years Considered
Figure 12. Global Cancer Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Cancer Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Cancer Gene Therapy Market Share by Region: 2022 VS 2029
Figure 15. Global Cancer Gene Therapy Market Share by Players in 2022
Figure 16. Global Top Cancer Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Gene Therapy as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Cancer Gene Therapy Revenue in 2022
Figure 18. North America Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Cancer Gene Therapy Market Share by Type (2018-2029)
Figure 20. North America Cancer Gene Therapy Market Share by Application (2018-2029)
Figure 21. North America Cancer Gene Therapy Market Share by Country (2018-2029)
Figure 22. United States Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Cancer Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Cancer Gene Therapy Market Share by Type (2018-2029)
Figure 26. Europe Cancer Gene Therapy Market Share by Application (2018-2029)
Figure 27. Europe Cancer Gene Therapy Market Share by Country (2018-2029)
Figure 28. Germany Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Cancer Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Cancer Gene Therapy Market Share by Type (2018-2029)
Figure 36. China Cancer Gene Therapy Market Share by Application (2018-2029)
Figure 37. Asia Cancer Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Cancer Gene Therapy Market Share by Type (2018-2029)
Figure 39. Asia Cancer Gene Therapy Market Share by Application (2018-2029)
Figure 40. Asia Cancer Gene Therapy Market Share by Region (2018-2029)
Figure 41. Japan Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Cancer Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Cancer Gene Therapy Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Cancer Gene Therapy Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Cancer Gene Therapy Market Share by Country (2018-2029)
Figure 51. Brazil Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Cancer Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Adaptimmune Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 58. Bluebird bio Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 59. Celgene Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 60. Shanghai Sunway Biotech Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 61. Shenzhen SiBiono GeneTech Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 62. SynerGene Therapeutics Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 63. Altor BioScience Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 64. Amgen Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 65. Argenx Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 66. BioCancell Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 68. Merck Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 69. OncoGenex Pharmaceuticals Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 70. Transgene Revenue Growth Rate in Cancer Gene Therapy Business (2018-2023)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs